DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 47 filers reported holding DEPOMED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,307,000 | +18.7% | 12,635,000 | +18.8% | 1.03% | -10.1% |
| Q3 2019 | $7,844,000 | -79.8% | 10,635,000 | -80.1% | 1.14% | -55.3% |
| Q2 2019 | $38,770,000 | -17.5% | 53,500,000 | -12.3% | 2.56% | +77.4% |
| Q1 2019 | $46,970,000 | +12.9% | 61,000,000 | 0.0% | 1.44% | +17.6% |
| Q4 2018 | $41,615,000 | -9.9% | 61,000,000 | +7.9% | 1.23% | +32.3% |
| Q2 2018 | $46,168,000 | +10.7% | 56,516,000 | +10.8% | 0.93% | +37.8% |
| Q1 2018 | $41,706,000 | -2.7% | 51,016,000 | 0.0% | 0.67% | -11.8% |
| Q4 2017 | $42,853,000 | +42.5% | 51,016,000 | +26.0% | 0.76% | +69.8% |
| Q3 2017 | $30,071,000 | +56.5% | 40,500,000 | +170.0% | 0.45% | +86.0% |
| Q2 2015 | $19,219,000 | -42.4% | 15,000,000 | -40.6% | 0.24% | -47.4% |
| Q1 2015 | $33,377,000 | +76.7% | 25,250,000 | +44.3% | 0.46% | +90.9% |
| Q4 2014 | $18,889,000 | -3.3% | 17,500,000 | -5.4% | 0.24% | -6.6% |
| Q3 2014 | $19,529,000 | – | 18,500,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|